DrugRisk Adds New Yaz Blood Clot Warning, Lawsuit News

Share Article

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The drug and medical device resource center DrugRisk.com is alerting women who’ve taken the birth control drugs Yaz or Yasmin that a new study added to the site shows those suffering from migraines may have higher risks of blood clots with these contraceptives.

“DrugRisk seeks to improve patient safety through education, with the latest updates of drug studies, recalls, and litigation news. While prior data has linked Yaz to blood clots, this study is the first to specifically addresses women suffering migraines,” explains DrugRisk representative Ryan Mayer.

The resource center recently added warnings from the American College of Obstetricians and Gynecologists that birth control pills containing drospirenone, like Yaz and Yasmin, may cause higher risks of blood clots.* France’s Health Ministry has also said they will stop reimbursements for the drugs over similar concerns.** Nevertheless, there has still been no official Yaz recall by the manufacturer.

Now, a new study on DrugRisk from Bringham and Women’s Faulkner Hospital in Boston found that, while combined hormone contraceptives like Yaz and Yasmin may raise blood clot risks for all women, the risks are significantly higher for those suffering migraines.***

DrugRisk has learned that thousands of patients have filed Yaz lawsuits over blood clots, which have been consolidated to a special Multi-District Litigation court in Illinois. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

In Bayer’s latest financial report, they disclose they have spent nearly $750 million to settle around 3,500 Yaz lawsuits for blood clot injuries, at an average of or around $214,000 per case.**** The company has also set aside more funds for additional claims.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

DrugRisk cautions victims who wish to learn about their legal options that they should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Chicago Tribune October 24, 2012, “Newer Pill has low blood clot risk: ob-gyn group”
**reuters.com/article/2013/01/03/france-contraception-idUSL5E9C31XG20130103
***foxnews.com/health/2013/01/15/migraines-with-aura-linked-to-heart-disease/
****Bayer Interim Financial Statement, Legal Notes and Business Development, September 30, 2012

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website